X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54032) 54032
Book Review (4964) 4964
Publication (3369) 3369
Newsletter (570) 570
Book Chapter (171) 171
Conference Proceeding (75) 75
Dissertation (46) 46
Magazine Article (28) 28
Book / eBook (11) 11
Newspaper Article (6) 6
Reference (5) 5
Data Set (4) 4
Government Document (4) 4
Web Resource (2) 2
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (47669) 47669
humans (44841) 44841
male (28565) 28565
female (27214) 27214
middle aged (24637) 24637
aged (22149) 22149
adenocarcinoma (18842) 18842
oncology (18097) 18097
cancer (16586) 16586
adult (14830) 14830
adenocarcinoma - pathology (13361) 13361
surgery (9309) 9309
carcinoma (8757) 8757
prognosis (8744) 8744
aged, 80 and over (8501) 8501
animals (8083) 8083
adenocarcinoma - surgery (7477) 7477
tumors (6701) 6701
neoplasm staging (6658) 6658
abridged index medicus (6464) 6464
metastasis (6261) 6261
chemotherapy (5728) 5728
adenocarcinoma - drug therapy (5446) 5446
retrospective studies (5388) 5388
treatment outcome (5340) 5340
research (5314) 5314
medicine & public health (5118) 5118
expression (5056) 5056
mice (5031) 5031
analysis (5000) 5000
survival (4858) 4858
care and treatment (4695) 4695
pancreatic cancer (4647) 4647
gastroenterology & hepatology (4311) 4311
adenocarcinoma - metabolism (4282) 4282
adenocarcinoma - blood (4262) 4262
follow-up studies (4211) 4211
pathology (4176) 4176
adenocarcinoma - genetics (4134) 4134
diagnosis (4113) 4113
immunohistochemistry (4072) 4072
adenocarcinoma - diagnosis (4068) 4068
adenocarcinoma - secondary (4027) 4027
risk factors (3894) 3894
health aspects (3840) 3840
lung neoplasms - pathology (3796) 3796
lung cancer (3777) 3777
adenocarcinoma - mortality (3684) 3684
survival rate (3616) 3616
cell line, tumor (3425) 3425
prostatic neoplasms - pathology (3285) 3285
pancreatic neoplasms - pathology (3106) 3106
colorectal cancer (3048) 3048
genetic aspects (2883) 2883
prostate cancer (2839) 2839
biomarkers, tumor - blood (2784) 2784
adenocarcinoma - therapy (2771) 2771
prostate-specific antigen - blood (2700) 2700
lymphatic metastasis (2650) 2650
antineoplastic combined chemotherapy protocols - therapeutic use (2641) 2641
patients (2543) 2543
stomach neoplasms - pathology (2543) 2543
gene expression (2524) 2524
urology & nephrology (2507) 2507
apoptosis (2496) 2496
therapy (2480) 2480
survival analysis (2479) 2479
prospective studies (2434) 2434
development and progression (2419) 2419
time factors (2386) 2386
adenocarcinoma - complications (2370) 2370
medicine (2332) 2332
radiotherapy (2318) 2318
disease-free survival (2300) 2300
mutation (2279) 2279
breast-cancer (2266) 2266
radiology, nuclear medicine & medical imaging (2245) 2245
article (2242) 2242
proteins (2228) 2228
adenocarcinoma - immunology (2204) 2204
cells (2198) 2198
neoplasm invasiveness (2188) 2188
cell biology (2154) 2154
neoplasm metastasis (2147) 2147
stomach cancer (2097) 2097
case-control studies (2077) 2077
research article (2072) 2072
biopsy (2068) 2068
combined modality therapy (2054) 2054
medical prognosis (2049) 2049
oncology, experimental (2047) 2047
adenocarcinoma - diagnostic imaging (2027) 2027
diagnosis, differential (2027) 2027
gastroenterology (1978) 1978
mortality (1976) 1976
gene expression regulation, neoplastic (1971) 1971
angiogenesis (1960) 1960
risk (1957) 1957
lung neoplasms - genetics (1947) 1947
prostatic neoplasms - blood (1932) 1932
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52231) 52231
Japanese (656) 656
German (425) 425
Chinese (312) 312
French (306) 306
Spanish (262) 262
Russian (239) 239
Italian (141) 141
Polish (80) 80
Portuguese (30) 30
Hungarian (19) 19
Dutch (17) 17
Danish (16) 16
Korean (15) 15
Czech (12) 12
Ukrainian (12) 12
Turkish (9) 9
Bulgarian (8) 8
Romanian (7) 7
Croatian (6) 6
Lithuanian (6) 6
Norwegian (5) 5
Serbian (4) 4
Finnish (3) 3
Swedish (3) 3
Greek (2) 2
Hebrew (2) 2
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 2017, Volume 109, Issue 4, p. djw266
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2018, Volume 13, Issue 1, pp. 97 - 105
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 10/2011, Volume 104, Issue 5, pp. 525 - 529
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis | Index Medicus
Journal Article
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 05/2017, Volume 125, Issue 5, pp. 332 - 340
In the current study, circulating epithelioid cells (CECs) are isolated from blood in patients with both benign and malignant pancreatic disease at similar... 
circulating tumor cells (CTC) | isolation by size of epithelial tumor cells (ISET) | circulating epithelial cells (CEC) | cytomorphological features | pancreas | SURVIVAL | LUNG | SIZE | DEVICE | TUMOR-CELLS | PATHOLOGY | ESOPHAGEAL | BREAST-CANCER | KRAS MUTATIONS | ONCOLOGY | Pancreatic Diseases - blood | Neuroendocrine Tumors - blood | Adenocarcinoma - pathology | Prognosis | Neoplastic Cells, Circulating - pathology | Common Bile Duct Neoplasms - blood | Humans | Carcinoma, Acinar Cell - pathology | Case-Control Studies | Pancreatic Diseases - pathology | Cystadenoma, Serous - blood | Pancreatitis, Chronic - blood | Carcinoma, Acinar Cell - blood | Epidermal Cyst | Ampulla of Vater - pathology | Neuroendocrine Tumors - pathology | Pancreatic Neoplasms - blood | Neoplasms, Cystic, Mucinous, and Serous - pathology | Adenocarcinoma - blood | Pancreatic Neoplasms - pathology | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - blood | Pancreatitis, Chronic - pathology | Adenoma - blood | Cholangiocarcinoma - pathology | Neoplasms, Cystic, Mucinous, and Serous - blood | Cholangiocarcinoma - blood | Adenoma - pathology | Bile Duct Neoplasms - blood | Bile Duct Neoplasms - pathology | Splenic Diseases | Common Bile Duct Neoplasms - pathology | Cystadenoma, Serous - pathology | Cell research | Research | Pancreatic diseases | Epithelial cells | Disease | Cancer | Index Medicus | Abridged Index Medicus | CEC | circulating epithelial cells | CTC | Circulating tumor cells
Journal Article
Journal Article
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 06/2017, Volume 15, Issue 1, pp. 126 - 126
Background: Discriminating between autoimmune pancreatitis (AIP), chronic pancreatitis (CP), and pancreatic ductal adenocarcinoma (PDAC) can be challenging. In... 
Autoimmune pancreatitis type 1 and type 2 | Cytokines | Chronic pancreatitis | Pancreatic ductal adenocarcinoma | RHEUMATOID-ARTHRITIS | MEDICINE, RESEARCH & EXPERIMENTAL | DIFFERENTIAL-DIAGNOSIS | COLONY-STIMULATING FACTOR | LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS | T-CELL | SERUM ANTIBODIES | CANCER | INTERLEUKIN-7 RECEPTOR | IDIOPATHIC CHRONIC-PANCREATITIS | ASSOCIATION | Autoimmune Diseases - physiopathology | Pancreatic Neoplasms - blood | Diagnosis, Differential | Pancreatic Neoplasms - diagnosis | Adenocarcinoma - blood | Humans | Middle Aged | Pancreatitis, Chronic - diagnosis | Male | Pancreatitis, Chronic - physiopathology | Autoimmune Diseases - diagnosis | Autoimmune Diseases - blood | Carcinoma, Pancreatic Ductal - blood | Adenocarcinoma - diagnosis | Pancreatitis, Chronic - blood | Adenocarcinoma - physiopathology | Carcinoma, Pancreatic Ductal - diagnosis | Adult | Female | ROC Curve | Carcinoma, Pancreatic Ductal - physiopathology | Cytokines - blood | Adenocarcinoma | Care and treatment | Research | Interleukins | Pancreatic cancer | Pancreatitis | Multiplexing | Disease | Pathogenesis | Blood | Optimization | Interleukin 7 | Immunology | Allografts | Granulocyte colony-stimulating factor | Rodents | Surgery | Colony-stimulating factor | Differential diagnosis | Diagnosis | Pancreas | Age | Invasiveness | Markers | Neutrophils | Histology | Interleukin 13 | Inflammation | Patients | Serum levels | Discrimination | Tumor necrosis factor | Rheumatoid arthritis | Pancreas transplantation | Leukocytes (granulocytic) | Differentiation | Autoimmune diseases | Index Medicus
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2015, Volume 26, Issue 10, pp. 2141 - 2149
The immune system is important in epithelial ovarian cancer (EOC). Interleukin-6 is associated with chemoresistance and an immune-suppressive tumor... 
Tumor immunity | Immunotherapy | Chemoresistance | Interleukin-6 | Ovarian cancer | Prognosis | Follow-Up Studies | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Receptors, Interleukin-6 - antagonists & inhibitors | Cystadenocarcinoma, Serous - pathology | Adenocarcinoma, Clear Cell - blood | Cystadenocarcinoma, Serous - drug therapy | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Adenocarcinoma, Mucinous - blood | Interleukin-6 - blood | Doxorubicin - analogs & derivatives | Adult | Female | Adenocarcinoma, Mucinous - drug therapy | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Doxorubicin - administration & dosage | Cystadenocarcinoma, Serous - blood | CA-125 Antigen - blood | Enzyme-Linked Immunosorbent Assay | Neoplasm Invasiveness | Carboplatin - administration & dosage | Ovarian Neoplasms - blood | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Biomarkers, Tumor - blood | Interferon-alpha - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Aged | Neoplasm Staging | Endometrial Neoplasms - blood | Interferon-gamma - blood | Adenocarcinoma, Clear Cell - drug therapy | Index Medicus
Journal Article
The American Journal of Gastroenterology, ISSN 0002-9270, 07/2010, Volume 105, Issue 7, pp. 1661 - 1669
OBJECTIVES: The prognosis of pancreatic cancer is still very poor, and the ability to detect pancreatic cancer in high-risk groups at an early stage is... 
DIAGNOSIS | CELLS | SYMPTOMATIC PATIENTS | COLORECTAL-CANCER | ADENOCARCINOMA | METALLOPROTEINASE | MICE | PANTETHEINASE | VANIN-1 |